Skip to content
Clinical Trials – home

Centre Hospitalier Universitaire Amiens Picardie

Verifiedinfo

France 1 Place Victor Pauchet, 80080 Amiens, France

  • 17 trials recruiting
  • Acute myeloid leukaemia · Malignant melanoma · Colitis ulcerative
  • Adults and children

About Specializations

Centre Hospitalier Universitaire Amiens Picardie in Amiens, France specialises in clinical trials of conditions such as Acute myeloid leukaemia, Malignant melanoma, Colitis ulcerative, Squamous cell carcinoma of head and neck, and other specialisations. This site conducts important research.

Main research areas of the site

Hematological Disorders

The medical center is at the forefront of research in hematological disorders, focusing on innovative treatments for conditions such as Primary Myelofibrosis, Chronic Lymphocytic Leukemia, and Acute Myeloid Leukemia. The center's research aims to improve patient outcomes through novel therapeutic approaches and personalized medicine.

  • Primary Myelofibrosis
  • Chronic Lymphocytic Leukemia
  • Acute Myeloid Leukemia

By integrating cutting-edge research with clinical practice, the center is advancing the understanding and treatment of complex blood disorders.

Gastroenterology

Specializing in gastroenterology, the center conducts pioneering research on Crohn's Disease and Ulcerative Colitis. The focus is on developing therapies that promote transmural healing and improve long-term patient outcomes.

  • Crohn's Disease
  • Ulcerative Colitis

Through innovative clinical trials, the center is enhancing therapeutic strategies and contributing to the global understanding of inflammatory bowel diseases.

Oncology

The center is a leader in oncology research, with a focus on Multiple Myeloma, Melanoma, and Breast Cancer. By exploring novel drug combinations and treatment protocols, the center aims to improve survival rates and quality of life for cancer patients.

  • Multiple Myeloma
  • Melanoma
  • Breast Cancer

Through collaborative research efforts, the center is at the forefront of developing new cancer therapies and advancing precision medicine.

Cardiology and Nephrology

In the fields of cardiology and nephrology, the center is investigating treatments for Acute Kidney Injury and Hyponatremia. The research focuses on improving cardiovascular outcomes and managing electrolyte imbalances in critical care settings.

  • Acute Kidney Injury
  • Hyponatremia

By integrating clinical research with patient care, the center is enhancing therapeutic approaches for complex cardiovascular and renal conditions.

Neurology and Autoimmune Diseases

The center is advancing research in neurology and autoimmune diseases, focusing on conditions such as Parkinson's Disease and Rheumatoid Arthritis. The goal is to develop therapies that improve neurological function and manage autoimmune responses.

  • Parkinson's Disease
  • Rheumatoid Arthritis

Through innovative research and clinical trials, the center is contributing to the development of new treatments that enhance patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
1 Place Victor Pauchet80080 AmiensFrance
Recruiting now
17 trials
Conditions studied
43
Partner status
Verified

More sites in AmiensFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

39 clinical trials

Crohn's disease

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Universita Degli Studi Di Milano Bicocca
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Autologous Adipose-Derived Stem Cells
  • Sponsor:Novadip Biosciences
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ropivacaine
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clobetasol Propionate
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ceftriaxone Sodium
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Exl01
  • Sponsor:Association Gercor
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Centre Hospitalier Universitaire De Nice
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Alpelisib
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.